Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioceres Crop Solutions (BIOX) Other Non-Current Assets (2017 - 2026)

Bioceres Crop Solutions' Other Non-Current Assets history spans 10 years, with the latest figure at $500000.0 for Q1 2026.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $500000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $500000.0, a N/A change, with the full-year FY2025 number at $2.0 million, up 215.18% from a year prior.
  • Other Non-Current Assets hit $500000.0 in Q1 2026 for Bioceres Crop Solutions, down from $2.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for BIOX hit a ceiling of $2.0 million in Q2 2025 and a floor of $444909.0 in Q2 2023.
  • Historically, Other Non-Current Assets has averaged $839860.6 across 5 years, with a median of $619841.0 in 2022.
  • Biggest five-year swings in Other Non-Current Assets: crashed 43.52% in 2022 and later soared 215.18% in 2025.
  • Tracing BIOX's Other Non-Current Assets over 5 years: stood at $619841.0 in 2022, then fell by 28.22% to $444909.0 in 2023, then soared by 42.63% to $634553.0 in 2024, then soared by 215.18% to $2.0 million in 2025, then crashed by 75.0% to $500000.0 in 2026.
  • Business Quant data shows Other Non-Current Assets for BIOX at $500000.0 in Q1 2026, $2.0 million in Q2 2025, and $634553.0 in Q2 2024.